$3.54
▼ $-0.12
(-3.28%)
Vol 10K
1
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$4.5M
ROE
-231.7%
Margin
-2023.9%
D/E
605.26
Beta
1.22
52W
$1–$38
Price Chart
Similar Stocks
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -231.7% | -231.7% | -231.7% | -231.7% | -231.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -2023.9% | -365.1% | -365.1% | -365.1% | -365.1% | -2023.9% |
| Gross Margin | 78.1% | — | — | — | — | — |
| D/E Ratio | — | 605.26 | 605.26 | 605.26 | 605.26 | 605.26 |
| Current Ratio | 0.55 | 0.54 | 0.54 | 0.54 | 0.54 | 0.55 |
Key Ratios
ROA (TTM)
-181.5%
P/S (TTM)
9.67
P/B
0.5
EPS (TTM)
$-1.51
CF/Share
$-1.11
52W High
$37.59
52W Low
$1.30
$1.30
52-Week Range
$37.59
How does SPRC compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
SPRC valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
9.7
▲
95%
above
peers
(5.0)
vs Peers
vs Industry
Pricier
P/B ratio
0.5
▼
77%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
SPRC profitability vs Pharmaceuticals peers
ROE
-231.7%
▼
327%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
-2023.9%
▼
4172%
below
peers
(-47.4%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-181.5%
▼
385%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
SPRC financial health vs Pharmaceuticals peers
D/E ratio
605.3
▲
39203%
above
peers
(1.5)
vs Peers
vs Industry
High debt
Current ratio
0.6
▼
84%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
1.2
▲
30%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
SPRC fundamentals radar
SPRC
Peer median
Industry
SPRC profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
SPRC vs peers: key metrics
Latest News
No related news yet